Joseph Michael Burnett Clear Point Neuro, Inc. (CLPT) insider trading activity

Joseph Michael Burnett is CEO and President of ClearPoint Neuro, Inc.. Currently has a direct ownership of 290,132 shares of CLPT, which is worth approximately $3.82 Million. The most recent transaction as insider was on Mar 12, 2025, when has been sold 23,405 shares (Common Stock) at a price of $13.18 per share, resulting in proceeds of $308,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 290K

16.23% 3M change

10.16% 12M change

Total Value Held $3.82 Million

JOSEPH MICHAEL BURNETT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2025	SELL Payment of exercise price or tax liability	$308,477 $13.18 p/Share	23,405 Reduced 7.46%	290,132 Common Stock
Mar 12 2025	BUY Exercise of conversion of derivative security	-	42,414 Added 11.92%	313,537 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$345,050 $13.19 p/Share	26,160 Reduced 8.8%	271,123 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	47,407 Added 13.75%	297,283 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	$1,137 $4.53 p/Share	251 Added 0.1%	249,876 Common Stock
Aug 20 2024	SELL Payment of exercise price or tax liability	$36,437 $11.26 p/Share	3,236 Reduced 1.28%	249,625 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$16,030 $4.58 p/Share	3,500 Added 1.37%	252,861 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$80,377 $5.74 p/Share	14,003 Reduced 5.32%	249,361 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$69,051 $6.24 p/Share	11,066 Reduced 4.03%	263,364 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	-	23,704 Added 7.95%	274,430 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$6,156 $5.77 p/Share	1,067 Added 0.42%	250,726 Common Stock
Jul 09 2023	SELL Payment of exercise price or tax liability	$40,282 $6.58 p/Share	6,122 Reduced 2.39%	249,659 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$12,884 $6.15 p/Share	2,095 Added 0.81%	255,781 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$48,038 $6.91 p/Share	6,952 Reduced 2.67%	253,686 Common Stock
Aug 20 2022	SELL Payment of exercise price or tax liability	$19,291 $13.24 p/Share	1,457 Reduced 0.56%	260,638 Common Stock
Aug 15 2022	SELL Open market or private sale	$303,193 $16.07 p/Share	18,867 Reduced 6.72%	262,095 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$124,604 $16.02 p/Share	7,778 Reduced 2.69%	280,962 Common Stock
Jul 09 2022	SELL Payment of exercise price or tax liability	$94,895 $14.24 p/Share	6,664 Reduced 2.27%	286,585 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	70,113 Added 19.3%	293,249 Common Stock
Nov 11 2021	SELL Open market or private sale	$168,800 $16.88 p/Share	10,000 Reduced 4.31%	221,787 Common Stock
Sep 21 2021	SELL Open market or private sale	$173,273 $17.98 p/Share	9,637 Reduced 3.99%	231,787 Common Stock
Aug 20 2021	BUY Grant, award, or other acquisition	-	14,688 Added 5.73%	241,424 Common Stock
Aug 15 2021	SELL Payment of exercise price or tax liability	$130,148 $17.7 p/Share	7,353 Reduced 3.14%	226,736 Common Stock
Jul 09 2021	SELL Payment of exercise price or tax liability	$60,756 $18.54 p/Share	3,277 Reduced 1.38%	234,089 Common Stock
Jun 21 2021	SELL Open market or private sale	$464,250 $18.57 p/Share	25,000 Reduced 9.53%	237,366 Common Stock

JMB

Joseph Michael Burnett

CEO and President

Solana Beach, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLPT shares.

Notify only if

Value

Insider Trading

Get notified when an Clear Point Neuro, Inc. insider buys or sells CLPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ClearPoint Neuro, Inc.

Track Activities on CLPT

Account